ÂÜÀòÂÒÂ×

Lars Grundemar is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as Deputy Chief Executive Officer and Chief Medical Officer at AGB-Pharma AB since 2022. Additionally, Lars holds the position of Director of the Board at Lead Biologics and AGB Development AB, while also actively participating as Organizer of the Lund Spring Symposium and as an Adjunct Professor at Lund University. With extensive experience as Managing Director at In Manu Medici LG AB since 1993 and as CEO and Chief Scientific Officer at Oncorena AB from 2017 to 2022, Lars has been instrumental in guiding various organizations through pivotal stages of development. Lars's educational background includes studies at Lund University and Cornell University, complemented by a Registered Specialist credential in Clinical Pharmacology.